XYMOGEN EP
Artriphen
Serving
2 Capsule(s)
Per container
45
Form
capsule-unknown
UPC
871149002206
DSLD
Formula hash
898dcbe24b43
Brand context
Catalog
101
products
With avoid flag
1
products
FDA recalls
0
history
CAERS
10
reports
Clean labelObjective label signals
Flagged excipients
0
none
FDA recalls
0
no recall history
CAERS reports
8
FDA consumer events
Certifications
0
none recorded
No authority-flagged excipients or recalls. · Every flag below links to the authority's published citation.
Supplement Facts
7 active ingredients| Ingredient | Amount | % DV |
|---|---|---|
| Vitamin C vitaminUNII · PQ6CK8PD0R UL · set5 effects | 60 mg | 100% |
| Vitamin E vitaminUNII · H4N855PNZ1 UL · set1 effect | 3.8 IU | 13% |
| Calcium mineralUNII · SY7Q814VUP UL · set6 effects | 20 mg | 2% |
| Selenium mineralUNII · H6241UJ22B UL · set3 effects | 3.8 mcg | 5% |
| Manganese mineralUNII · 42Z2K6ZL8P UL · set2 effects | 3 mg | 150% |
| Sodium mineralUNII · 9NEZ333N27 | 10 mg | 1% |
| artriphen Proprietary Blend Proprietary Blend (Combination)other | 1062 mg | — |
What this product supports · authorized claims
13 authority-backed effects
Rolled up from EFSA / FDA / NIH ODS authorized function claims on this product's active ingredients. Each row shows which ingredients contribute.
- from: Calcium · Manganese
- from: Calcium
- from: Calcium
- from: Calcium
- from: Calcium
- from: Calcium
- from: Selenium · Vitamin C
- from: Selenium
- from: Vitamin C
- from: Vitamin C
- from: Manganese
- from: Selenium · Vitamin C · Vitamin E
- from: Vitamin C
FDA CAERS · adverse event context
8
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.
CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →
Other ingredients
HPMC · Microcrystalline Cellulose · Magnesium Stearate